Trials / Completed
CompletedNCT01028443
Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
The use of topical Cyclosporine A early after an episode of endothelial graft rejection after penetrating keratoplasty and continuing its administration for 6 months can reduce the course of that episode and recurrence of the rejection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sandimmune | |
| DRUG | Artelose |
Timeline
- First posted
- 2009-12-09
- Last updated
- 2009-12-09
Locations
2 sites across 1 country: Iran
Source: ClinicalTrials.gov record NCT01028443. Inclusion in this directory is not an endorsement.